The Food and Drug Administration has given so-called "breakthrough" status to a treatment that uses the once-feared polio virus to target aggressive forms of brain cancer, in the hope of speeding it to market. The therapy, developed at Duke University, hopes to use the virus’ debilitating properties to help fight cancer instead of harming its host, <a href="http://www.cbsnews.com/news/promising-duke-university-polio-brain-cancer-trial-given-breakthrough-status-60-minutes/">CBS News reported Thursday.</a> The experimental treatment was the brainchild of molecular biologist Matthias Gromeier. By removing a certain genetic sequence and replacing it with material from the common cold virus, the polio would not be able to cause the incapacitating symptoms that once afflicted President Franklin D. Roosevelt and numerous others because it would be unable to reproduce in normal cells. However, the altered version of polio could still reproduce in
A possible breakthrough in the cure of cancer was tested and had an amazing result.
After tracking an early-stage academic research project that uses a genetically engineered form of the poliovirus to help shrink certain brain tumors for a year, CBS’ 60 Minutes reports that the treatment has now been given a “Breakthrough” status from the FDA.
What does it mean when the FDA designates research with "breakthrough status"? CBS didn't give an adequate explanation when it reported CANCER BREAKTHROUGH
A bold experiment from Duke University that uses the polio virus to fight a deadly form of brain cancer will now be fast-tracked by the FDA
The Food and Drug Administration has approved a new therapy that uses the once-feared polio virus to target aggressive forms of brain cancer.